戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 luding increased head-twitch response to the hallucinogenic 5-HT(2A) agonist DOI [1-(2,5-dimethoxy-4-
2 he psychosis-like effects induced in mice by hallucinogenic 5-HT(2A) agonists.
3                        Administration of the hallucinogenic 5-HT(2A/2C) agonist 1-[2, 5-dimethoxy-4-i
4 FC and attenuates the in vivo actions of the hallucinogenic 5-HT(2A/2C) receptor agonist (-)2,5-dimet
5 investigated using central injections of the hallucinogenic 5-HT2 agonist DOI and the novel 5-HT2A an
6                          Administration of a hallucinogenic 5-HT2A /2C receptor agonist, but not a 5-
7 bility that regulation of BDNF expression by hallucinogenic 5-HT2A receptor agonists leads to adaptat
8 ic serotonin(2A) receptors, the key site for hallucinogenic actions.
9                    Methods of modulating the hallucinogenic activity of LSD by functionalization at p
10     Although it is generally considered that hallucinogenic activity results from 5-HT(2A) receptor a
11 tionally constrained analogues of the potent hallucinogenic agent, N,N-diethyllysergamide, LSD-25.
12 n 5-HT(2A) receptor, the presumed target for hallucinogenic agents, and a receptor affinity profile i
13 s agonist, serotonin, to a synthetic 5-HT2AR hallucinogenic agonist, 2,5-dimethoxy-4-iodoamphetamine
14                                    5-HT(2A)R hallucinogenic agonists exhibit biased agonism toward G(
15                                  Ibogaine, a hallucinogenic alkaloid proposed as a treatment for opia
16                                  Ibogaine, a hallucinogenic alkaloid with purported anti-addiction pr
17 aphy-mass spectrometry (LC-MS) results found hallucinogenic alkaloids scopolamine and atropine in the
18 xygen substituents that are found in typical hallucinogenic amphetamines such as 4b (DOB).
19 cal survey revealed that psychostimulant and hallucinogenic amphetamines, numerous ergoline derivativ
20 different mechanisms may underlie ibogaine's hallucinogenic and anti-addictive effects.
21 HT2A receptors, a proposed site of action of hallucinogenic and atypical antipsychotic drugs.
22                                              Hallucinogenic and nonhallucinogenic 2AR agonists both r
23 The molecular basis of ligand selectivity of hallucinogenic and nonhallucinogenic compounds of varyin
24 These compounds are thought to mediate their hallucinogenic and therapeutic effects through the serot
25 s mediate their actions-both therapeutic and hallucinogenic-are not understood, although activation o
26 serotonin release and correctly predicts the hallucinogenic behavioral effects of structurally simila
27                                          The hallucinogenic chemicals (+/-)-2,5-dimethoxy-4-iodoamphe
28                             Ketamine, a mild hallucinogenic class C drug, is the fastest growing 'par
29                              Psilocybin is a hallucinogenic compound that is showing promise in the a
30          In this review, the pharmacology of hallucinogenic compounds is summarized by underscoring t
31                     These include use of non-hallucinogenic derivatives, which are currently the focu
32        Salvinorin A is a naturally occurring hallucinogenic diterpenoid from the plant Salvia divinor
33 of group II mGlu receptor agonists to reduce hallucinogenic drug action in this region is believed to
34 rid" molecules of the two major prototypical hallucinogenic drug classes, the phenethylamines and the
35 oids represent one of the most commonly used hallucinogenic drug classes.
36 r-1, and egr-2 expression in response to the hallucinogenic drug DOI.
37 asing recreational use of this stimulant and hallucinogenic drug has raised concerns about its potent
38 for selective and sensitive detection of the hallucinogenic drug N,N-dimethyltryptamine (DMT) was dev
39 tate, the aura of temporal lobe epilepsy and hallucinogenic drug states.
40                                   Individual hallucinogenic drugs are usually studied in participants
41                                      Because hallucinogenic drugs primarily have serotonin(2A) recept
42                               The effects of hallucinogenic drugs resemble some of the core symptoms
43                             Psychedelics are hallucinogenic drugs that alter brain activity and facil
44 ental evidence links both visual flicker and hallucinogenic drugs to upward and downward modulations
45 s unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes
46 the free press, an El Greco fallacy fallacy, hallucinogenic drugs, blue bananas, subatomic particles,
47                                         Like hallucinogenic drugs, full-field flickering visual stimu
48                               The effects of hallucinogenic drugs, such as psilocybin and lysergic ac
49 g serotonergic system may mediate ibogaine's hallucinogenic effect; and (4) 18-MC probably has no aff
50                                           If hallucinogenic effects are correlated with arachidonic a
51 ic phenethylamines can have psychoactive and hallucinogenic effects due to their high affinity with t
52 sion in the cerebral cortex in mediating the hallucinogenic effects of 5-HT2A agonists such as DOI is
53  garden herb well known for its euphoric and hallucinogenic effects on domestic cats,(1-3) for its me
54                        In addition to marked hallucinogenic effects, LSD exerts methylenedioxymethamp
55 e cortical neuroplasticity in the absence of hallucinogenic effects.
56 rooms, and blocking 5-HT2A receptor-mediated hallucinogenic effects.
57 -pulse inhibition and developed spontaneous 'hallucinogenic' head-twitches, altogether suggesting sch
58                                  Ibogaine, a hallucinogenic indole alkaloid, has been proposed as a t
59 igin - were analysed for the presence of non-hallucinogenic indole compounds.
60 ipophilic alkaloids, poisonous steroids, and hallucinogenic indolethylamines such as DMT, 5-methoxy-D
61 A)-selective 5-MeO-DMT analogue is devoid of hallucinogenic-like effects while retaining anxiolytic-l
62 fects of the psychedelic without driving its hallucinogenic-like effects.
63 enous neurotransmitter and is not considered hallucinogenic, metabolites of serotonin also have high
64 norin A is the major active component of the hallucinogenic mint plant Salvia divinorum Epling and Ja
65                                            A hallucinogenic mushroom, Psilocybe cubensis, was domesti
66 sure to psilocybin, the active ingredient of hallucinogenic mushrooms.
67  investigated its complexes with ibogaine, a hallucinogenic natural product with psychoactive and ant
68 engineer tabernanthalog-a water-soluble, non-hallucinogenic, non-toxic analogue of ibogaine that can
69  the potential for improved efficacy without hallucinogenic or rewarding actions.
70 conformationally restricted analogues of the hallucinogenic phenethylamine 1 (2,5-dimethoxy-4-bromoph
71       This also implies, therefore, that the hallucinogenic phenethylamines cannot be directly superi
72  the aromatic methoxy groups in prototypical hallucinogenic phenylalkylamines 1 and 2.
73 he neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint family that has been us
74 logical areas in South America suggests that hallucinogenic plants moved across significant distances
75  lysergic acid diethylamide (LSD) with lower hallucinogenic potential and potent neuroplasticity-prom
76 lopment of ibogaine, including its toxicity, hallucinogenic potential and tendency to induce cardiac
77 sicochemical properties, and possess reduced hallucinogenic potential as compared to their DMT counte
78 etamine [MDMA]), is an amphetamine with some hallucinogenic properties at high doses.
79 ns for psychiatric disorders by removing the hallucinogenic properties while retaining the potential
80                      However, because of its hallucinogenic properties, studies investigating its abu
81 We further used psychLight to identify a non-hallucinogenic psychedelic analog, which produced rapid-
82 rophysiological recordings revealed that the hallucinogenic-receptor agonists' effects on functional
83    Salvinorin A, the active component of the hallucinogenic sage Salvia divinorum, is an apparently s
84     The KOR-G-protein complexes are bound to hallucinogenic salvinorins or highly selective KOR agoni
85 ramework for evaluating psychedelics and non-hallucinogenic serotonin 2A (5-HT(2A)) receptor agonists
86 algesics has been hindered by the associated hallucinogenic side effects(2).
87                               However, their hallucinogenic side-effects often preclude their clinica
88 and the development of 5-HT2AR-dependent non-hallucinogenic therapeutics.
89 ard alkaloid species and, in particular, the hallucinogenic tropane alkaloid functionality within com
90    The results indicate that fluorination of hallucinogenic tryptamines generally has little effect o
91     A series of fluorinated analogues of the hallucinogenic tryptamines N,N-diethyltryptamine (DET),
92 psychedelic compound to produce a safer, non-hallucinogenic variant that has therapeutic potential.